Difficulty: Medium
Average Score: 81%
Practice
Indicate the neuromuscular blocker, which causes tachycardia:
Correct answer
C
Rationale
In the context of pharmacology and neuromuscular blockers, the correct answer to the question is C) Pancuronium. Pancuronium is a non-depolarizing neuromuscular blocker that can cause tachycardia as a side effect. This occurs due to its potential to stimulate muscarinic receptors, leading to increased heart rate.
Option A) Tubocurarine is a neuromuscular blocker that does not typically cause tachycardia. It is a non-depolarizing agent but is not associated with direct stimulation of muscarinic receptors leading to increased heart rate.
Option B) Atracurium is another non-depolarizing neuromuscular blocker that does not commonly cause tachycardia. Its mechanism of action does not involve direct effects on heart rate.
Option D) Succinylcholine is a depolarizing neuromuscular blocker that can lead to bradycardia rather than tachycardia. Its effects on the autonomic nervous system differ from those of Pancuronium.
Understanding the specific side effects and mechanisms of action of different neuromuscular blockers is crucial in clinical practice. This knowledge helps healthcare professionals anticipate and manage potential complications during anesthesia and other procedures where these medications are used.
Option A) Tubocurarine is a neuromuscular blocker that does not typically cause tachycardia. It is a non-depolarizing agent but is not associated with direct stimulation of muscarinic receptors leading to increased heart rate.
Option B) Atracurium is another non-depolarizing neuromuscular blocker that does not commonly cause tachycardia. Its mechanism of action does not involve direct effects on heart rate.
Option D) Succinylcholine is a depolarizing neuromuscular blocker that can lead to bradycardia rather than tachycardia. Its effects on the autonomic nervous system differ from those of Pancuronium.
Understanding the specific side effects and mechanisms of action of different neuromuscular blockers is crucial in clinical practice. This knowledge helps healthcare professionals anticipate and manage potential complications during anesthesia and other procedures where these medications are used.